Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Paratek Pharmaceuticals, Inc. has good growth characteristics. Paratek Pharmaceuticals, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Paratek Pharmaceuticals, Inc. .
Log in to see more information.
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based up...

News

StockNews.com Initiates Coverage on Paratek Pharmaceuticals (NASDAQ:PRTK)
StockNews.com Initiates Coverage on Paratek Pharmaceuticals (NASDAQ:PRTK)

Ticker Report StockNews.com initiated coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the specialty...\n more…

Deltec Asset Management LLC Takes $156,000 Position in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)
Deltec Asset Management LLC Takes $156,000 Position in Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)

Ticker Report Deltec Asset Management LLC purchased a new stake in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK Free Report) during the 2nd quarter, according to its most recent 13F filing with the...\n more…

Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by Analysts at StockNews.com
Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by Analysts at StockNews.com

Ticker Report StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on...\n more…

Gurnet Point, Novo complete acquisition of Paratek Pharmaceuticals
Gurnet Point, Novo complete acquisition of Paratek Pharmaceuticals

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.

Globe Newswire CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital ( Gurnet Point ) and Novo Holdings A/S ( Novo Holdings ) announced today the completion of their acquisition of Paratek...\n more…

Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S
Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S

Globe Newswire BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ( Paratek ) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of...\n more…